Literature DB >> 2600084

A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization.

A Chantry1, N A Gregson, P Glynn.   

Abstract

Brain myelin membrane preparations contain a metalloproteinase activity which degrades myelin basic protein (MBP). The activity was associated with lentil lectin-binding glycoproteins solubilized from myelin and could be detected in the presence of the detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate (CHAPS). The metalloproteinase represented about 5% of this glycoprotein fraction and was isolated from it by chromatography on DEAE-Sephacel, CM-Sepharose, and Superose 6. The proteinase had an apparent relative molecular weight (Mr) of approximately 58,000 both by gel filtration and by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The Mr value was unaffected by the presence of reducing agents but was diminished to about 52,000 by treating the proteinase with endoglycosidase F. The purified proteinase cleaved many bonds in MBP but did not generate trichloroacetic acid-soluble products. Two major polypeptides, putatively MBP1-73 and MBP74-170, were prominent in digests of MBP by either the purified enzyme or myelin membranes. The proteinase was active between pH 7 and 9 and was inhibited by phenanthroline and dithiothreitol but not phosphoramidon or inhibitors of serine or cysteine proteinases. Histones, but not azocasein, also served as substrates for the proteinase. From its enzymic and molecular characteristics the myelin-derived metalloproteinase appears distinct from previously described enzymes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600084

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Molecular cloning of MADM: a catalytically active mammalian disintegrin-metalloprotease expressed in various cell types.

Authors:  L Howard; X Lu; S Mitchell; S Griffiths; P Glynn
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  A novel metalloproteinase originally isolated from brain myelin membranes is present in many tissues.

Authors:  A Chantry; P Glynn
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

3.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.

Authors:  S Lammich; E Kojro; R Postina; S Gilbert; R Pfeiffer; M Jasionowski; C Haass; F Fahrenholz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Cleavage of the P0 glycoprotein of the rat peripheral nerve myelin: tentative identification of cleavage site and evidence for the precursor-product relationship.

Authors:  H C Agrawal; D Agrawal; A W Strauss
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

5.  Zinc metalloproteinases and amyloid Beta-Peptide metabolism: the positive side of proteolysis in Alzheimer's disease.

Authors:  Mallory Gough; Catherine Parr-Sturgess; Edward Parkin
Journal:  Biochem Res Int       Date:  2010-09-30

6.  Degradation of myelin basic protein by a membrane-associated metalloprotease: neural distribution of the enzyme.

Authors:  A Chantry; N Gregson; P Glynn
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 7.  ADAM function in embryogenesis.

Authors:  Dominique Alfandari; Catherine McCusker; Hélène Cousin
Journal:  Semin Cell Dev Biol       Date:  2008-09-30       Impact factor: 7.727

8.  Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis.

Authors:  Gurumoorthy Krishnamoorthy; Amit Saxena; Lennart T Mars; Helena S Domingues; Reinhard Mentele; Avraham Ben-Nun; Hans Lassmann; Klaus Dornmair; Florian C Kurschus; Roland S Liblau; Hartmut Wekerle
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

Review 9.  Molecular rationale for the pharmacological treatment of Alzheimer's disease.

Authors:  Martina Zimmermann; Fabrizio Gardoni; Monica Di Luca
Journal:  Drugs Aging       Date:  2005       Impact factor: 4.271

Review 10.  A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions.

Authors:  Nives Giebeler; Paola Zigrino
Journal:  Toxins (Basel)       Date:  2016-04-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.